Literature DB >> 19361907

Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland.

Kari A O Tikkinen1, Theodore M Johnson, Teuvo L J Tammela, Harri Sintonen, Jari Haukka, Heini Huhtala, Anssi Auvinen.   

Abstract

BACKGROUND: Nocturia (ie, waking at night to void) is common and disrupts sleep. Traditionally, one nightly episode has been regarded as clinically meaningless, yet the justification for this belief remains weak.
OBJECTIVE: To evaluate the association among frequency of nocturia and bother and health-related quality of life (HRQoL). DESIGN, SETTING, AND PARTICIPANTS: In 2003-2004, a survey was mailed to a random sample of 6000 subjects aged 18-79 yr who were identified from the Finnish Population Register Centre (response proportion was 62.4%; 53.7% were females). MEASUREMENTS: HRQoL and bother from nocturia were examined in relation to self-reported nocturia frequency (using the American Urological Association Symptom Index and the Danish Prostatic Symptom Score). Bother from nocturia was assessed on a four-point scale (none, small, moderate, major). HRQoL was measured with the generic 15D instrument on a 0-1 scale with a minimum clinically important difference of 0.03. RESULTS AND LIMITATIONS: Degree of bother increased with nocturia frequency (p<0.01). The most commonly cited degree of bother for those with one, two, and three nightly voids was no bother, small bother, and moderate bother, respectively. The mean age-adjusted 15D score for men (and women) without nocturia was 0.953 (0.950) and 0.925 (0.927) with one void per night, 0.898 (0.890) with two voids per night, and 0.833 (0.840) with three or more voids per night. Statistically significant decreases were found in 15D score and in all 15D dimensions except eating. Although the response rate was high, approximately one third of those contacted did not participate in the study.
CONCLUSIONS: At least two voids per night is associated with impaired HRQoL. The majority of people report having bother when the number of nocturia episodes is two and moderate or major bother when the number is three or more. One void per night does not identify subjects with interference from nocturia and, thus, is not a suitable criterion for clinically relevant nocturia. 2009 European Association of Urology. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19361907     DOI: 10.1016/j.eururo.2009.03.080

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  87 in total

1.  Prevalence and predictors of overactive bladder in nonpregnant nulliparous women below 65 years of age.

Authors:  Dudley Robinson; Sigvard Åkervall; Adrian Wagg; Christopher Chapple; Ian Milsom; Maria Gyhagen
Journal:  Int Urogynecol J       Date:  2017-08-04       Impact factor: 2.894

2.  The association of nocturia with incident falls in an elderly community-dwelling cohort.

Authors:  C P Vaughan; C J Brown; P S Goode; K L Burgio; R M Allman; T M Johnson
Journal:  Int J Clin Pract       Date:  2010-04       Impact factor: 2.503

3.  Nocturia in Patients With Multiple Sclerosis.

Authors:  Benoit Peyronnet; Lauren B Krupp; W Stuart Reynolds; Xavier Gamé; Gérard Amarenco; Jean-Nicolas Cornu; Lana Zhovtis Ryerson; Carrie Lyn Sammarco; Jonathan E Howard; Robert W Charlson; Roger R Dmochowski; Benjamin M Brucker
Journal:  Rev Urol       Date:  2019

Review 4.  Incontinence in the elderly, 'normal' ageing, or unaddressed pathology?

Authors:  William Gibson; Adrian Wagg
Journal:  Nat Rev Urol       Date:  2017-04-11       Impact factor: 14.432

5.  Differences in the Association of Nocturia and Functional Outcomes of Sleep by Age and Gender: A Cross-sectional, Population-based Study.

Authors:  Camille P Vaughan; Constance H Fung; Alison J Huang; Theodore M Johnson; Alayne D Markland
Journal:  Clin Ther       Date:  2016-10-15       Impact factor: 3.393

6.  Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies.

Authors:  Matthias Oelke; Richard Berges; Sandra Schläfke; Martin Burkart
Journal:  World J Urol       Date:  2014-06-18       Impact factor: 4.226

7.  Nocturia improvement in the combination of Avodart(®) and tamsulosin (CombAT) study.

Authors:  Matthias Oelke; Claus G Roehrborn; Carlos D'Ancona; Timothy H Wilson; Ramiro Castro; Michael Manyak
Journal:  World J Urol       Date:  2014-05-08       Impact factor: 4.226

8.  Diagnosis and management of nocturia in current clinical practice: who are nocturia patients, and how do we treat them?

Authors:  Siri Drangsholt; Maria Juliana Arcila Ruiz; Benoit Peyronnet; Nirit Rosenblum; Victor Nitti; Benjamin Brucker
Journal:  World J Urol       Date:  2018-10-04       Impact factor: 4.226

9.  Nocturia: focus on etiology and consequences.

Authors:  Jeffrey P Weiss
Journal:  Rev Urol       Date:  2012

10.  Association of bowel habits with lower urinary tract symptoms in men: findings from the 2005-2006 and 2007-2008 National Health and Nutrition Examination Survey.

Authors:  Kerri L Thurmon; Benjamin N Breyer; Bradley A Erickson
Journal:  J Urol       Date:  2012-10-11       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.